Bausch Health Companies (BHC) Current Assets (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Current Assets came in at $6.0 billion in Q1 2026, up 4.29% year-on-year from $5.7 billion in Q1 2025, and down 2.91% quarter-over-quarter from $6.2 billion in Q4 2025.
Bausch Health Companies (BHC) Current Assets (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Current Assets across 18 years of filings, most recently posting $6.0 billion for Q1 2026.
- Current Assets for Q1 2026 came in at $6.0 billion, up 4.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 billion (up 4.29% YoY), and the FY2025 annual result was $6.2 billion, up 6.63% from the prior year.
- Current Assets came in at $6.0 billion for Q1 2026 at Bausch Health Companies, down from $6.2 billion in the prior quarter.
- In the past five years, Current Assets ranged from a high of $6.5 billion in Q2 2025 to a low of $4.0 billion in Q3 2022.
- The 5-year median for Current Assets is $5.4 billion (2022), against an average of $5.4 billion.
- Peak annual rise in Current Assets reached 31.76% in 2023, while the deepest fall reached 27.4% in 2023.
- Bausch Health Companies' Current Assets stood at $4.2 billion in 2022, then jumped by 31.76% to $5.6 billion in 2023, then climbed by 3.18% to $5.8 billion in 2024, then rose by 6.63% to $6.2 billion in 2025, then decreased by 2.91% to $6.0 billion in 2026.
- The last three Current Assets figures came in at $6.0 billion (Q1 2026), $6.2 billion (Q4 2025), and $6.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.71 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 6.47 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 2.87 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.44 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.58 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.36 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 942.29 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.05 Bn |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | 5.98 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.98 Bn |
| Dec 31, 2025 | 6.16 Bn |
| Sep 30, 2025 | 6.25 Bn |
| Jun 30, 2025 | 6.51 Bn |
| Mar 31, 2025 | 5.73 Bn |
| Dec 31, 2024 | 5.77 Bn |
| Sep 30, 2024 | 5.35 Bn |
| Jun 30, 2024 | 5.21 Bn |
| Mar 31, 2024 | 5.40 Bn |
| Dec 31, 2023 | 5.60 Bn |
| Sep 30, 2023 | 5.05 Bn |
| Jun 30, 2023 | 4.46 Bn |
| Mar 31, 2023 | 4.24 Bn |
| Dec 31, 2022 | 4.25 Bn |
| Sep 30, 2022 | 4.01 Bn |
| Jun 30, 2022 | 5.42 Bn |
| Mar 31, 2022 | 5.84 Bn |
| Dec 31, 2021 | 5.61 Bn |
| Sep 30, 2021 | 5.32 Bn |
| Jun 30, 2021 | 5.45 Bn |